Health Care/Hospital

Antengene to Present Results from Three Programs at the 2024 SITC Annual Meeting

SHANGHAI and HONG KONG, Oct. 5, 2024 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cance...

2024-10-07 13:14 1896

/C O R R E C T I O N -- APAC Liver Disease Alliance/

In the news release, APAC LIVER DISEASE ALLIANCE HOSTS "HEP-FREE: ELIMINATING ASIA'S SILENT PUBLIC HEALTH THREAT BY 2030" SUMMIT IN BANGKOK ON 1 OCTOBER 2024 , issued02-Oct-2024 by APAC Liver Disease Alliance over PR Newswire, we are advised by the company that the photo caption, should read "Kamo...

2024-10-07 11:34 3282

Alpha Asia Aesthetics: an Instagram-Worthy Aesthetic Clinic Launched in Partnership with Entrepreneur Investor Ivan Lee

SINGAPORE, Oct. 7, 2024 /PRNewswire/ -- Influencer doctor Dr Jeanel Goh and the famed founder of Thai Express, MrIvan Lee, have come together to leave their mark onSingapore's Aesthetic Medicine scene with their brainchild: Alpha Asia Aesthetics . Leveraging on Dr...

2024-10-07 10:10 1876

Medinol Announces Successful First-in-Human Implantation of ChampioNIR Drug-Eluting Peripheral Stent System in Australia

TEL AVIV, Israel, Oct. 7, 2024 /PRNewswire/ -- Medinol Ltd. is pleased to announce the successful First-in-Human (FIH) implantation of the ChampioNIR Drug-Eluting Peripheral Stent by DrsGerard S.Goh and Thodur Vasudevan of the Alfred Hospital inMelbourne Australia, introducing a revolutionary adv...

2024-10-07 06:00 1350

PROMISING CELL THERAPY OFFERS HOPE FOR RELAPSED OR REFRACTORY T-CELL LEUKAEMIA

Fratricide-resistant CD7 CAR-T therapy by NUS proves effective in treating relapsed or refractory T-cell leukaemia SINGAPORE, Oct. 5, 2024 /PRNewswire/ -- A new cell therapy, targeting CD7 on leukaemia cells, gives a potentially effective treatment for patients with T-cell acute lymphoblastic le...

2024-10-05 06:00 7304

Cyient DLM Expands Global Footprint with Strategic Acquisition of US-Based EMS Manufacturer

HYDERABAD, India, Oct. 4, 2024 /PRNewswire/ -- Cyient DLM, a leading integrated electronics manufacturing company, announced today its acquisition of Altek Electronics, a prominent EMS (Electronic Manufacturing Services) company based inthe United States. This strategic move marks a significant m...

2024-10-04 21:00 4655

TiumBio Announces First Patient Dosed in Phase 2 Clinical Trial of Oral Immuno-Oncology Drug TU2218

* TU2218 is a potentially first-in-class dual inhibitor targeting transforming growth factor beta receptor 1 (TGFR1) and vascular endothelial growth factor receptor 2 (VEGFR2) * The first patient with head and neck squamous cell carcinoma was dosed in the Phase 2a clinical trial of TU2218 *...

2024-10-04 20:00 1724

Clarivate in partnership with Abiquifi Announces Annual Summit LATAM Agenda

Top industry leaders to explore AI, data, strategic partnerships, and innovation opportunities inLatin America at premier Life Sciences event LONDON, Oct. 4, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) a leading global provider of transformative intelligence, today announced the full agenda ...

2024-10-04 15:00 1890

Sirnaomics Has Been Subscribed for 17,527,696 Subscription Shares, New Capital Injection to Promote Business Growth and Development

HONG KONG, GERMANTOWN, Md., and SUZHOU, China,, Oct. 4, 2024 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", together with its subsidiaries, the "Group" or " Sirnaomics"; stock code: 2257.HK), a leading biopharmaceutical company engaged in the discovery and development of advanced RNAi therapeutic...

2024-10-04 13:03 5658

ABL Bio Announces Clinical Collaboration to Evaluate ABL103 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Solid Tumors

- MSD will supply KEYTRUDA to be evaluated in combination with ABL Bio's ABL103 in a Phase1b/2 clinical trial SEONGNAM, South Korea, Oct. 4, 2024 /PRNewswire/ -- ABL Bio (CEO Sang Hoon Lee ), a company specializing in bispecific antibodies, today announced that it has entered into a clinical tria...

2024-10-04 12:40 2457

Xinhua Silk Road: Ex-champ Bruno Hasulyo starts new career to bolster SUP in eastern China metropolis

BEIJING, Oct. 4, 2024 /PRNewswire/ -- Born in Hungary, Bruno Hasulyo is not just a professional athlete but also an adventurer at heart and a visionary entrepreneur. His life journey has been driven by a singular goal -- becoming an iconic figure in the world of stand-up paddling (SUP) and usher...

2024-10-04 12:30 7670

Siriraj Enhances Diagnostic Capabilities, a Crucial Factor for Medical Care

BANGKOK, Oct. 4, 2024 /PRNewswire/ -- Siriraj Hospital excels in maintaining its high standards for every service, including diagnostics through the integration of cutting-edge technology into its medical services, furthering its mission to become a global leader in healthcare. The hospital is fo...

2024-10-04 11:18 2291

Agilent and National University of Singapore Launch Center of Excellence in Cell Metabolism to Improve Population Health

Center will enable targeted and untargeted metabolic profiling for population-based large-scale cohorts across translational research SINGAPORE, Oct. 4, 2024 /PRNewswire/ -- Agilent Technologies Inc.

2024-10-04 09:00 2842

First Patient Dosed in Phase II 'CA-NINE' Trial of TLX250-CDx for Detection of Recurrent Kidney Cancer After Surgery

MELBOURNE, Australia, Oct. 4, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in a Phase II trial exploring the clinical utility of Telix's first-in-class investigational PET[1] agent, TLX250-CDx (89Zr-girentu...

2024-10-04 04:00 2929

IBC launches RadSep, Inc.: Best-in-class, highly selective separations using Molecular Recognition Technology™ (MRT™) for production of critical radioisotopes essential to cancer therapies

* Best-in-class, highly selective separations technology for the radiopharmaceuticals industry * Exhibitor at the European Association of Nuclear Medicine (EANM) Congress in Hamburg, Germany 20-23 October 2024 at Booth S14 (Exhibition Hall 3) * Over 36 years of experience with first generatio...

2024-10-03 22:15 1776

WELLlife COVID-19/Influenza A&B Home Test on Sale for Amazon Prime Day

Standfirst: Welllife, a Flu home test in addition to COVID-19 BOLINGBROOK, Ill., Oct. 3, 2024 /PRNewswire/ -- WELLlife, a leading innovator in medical diagnostic and testing solutions, is increasing accessibility to respiratory illness testing this flu season. The WELLlife COVID-19/Influenza A&B...

2024-10-03 21:00 1222

The Exosome Production Method Patent by Panacell Biotech Registered as Original Technology

SEOUL, South Korea, Oct. 3, 2024 /PRNewswire/ -- Panacell Biotech Co., Ltd. (Panacell Biotech) announced that the patent related to their exosome manufacturing method filed last year was registered as a core technology in the patent registry onAugust 7, 2024, following the Patent Act. Panacell B...

2024-10-03 20:00 1767

Veritas Genetic participates in a groundbreaking study highlighting the importance of polygenic risk scores in the clinical management of breast cancer patients

* The study, conducted in collaboration with the Department of Biomedicine and Prevention at the University of Rome Tor Vergata and Tor Vergata University Hospital, underscores the relevance of polygenic risk scores (PRS) in risk stratification for patients with a genetic predisposition to brea...

2024-10-03 14:00 1868

CNN's 'Tomorrow Transformed' explores how the future of healthcare is connecting lives

HONG KONG, Oct. 3, 2024 /PRNewswire/ -- Since the dawn of healthcare, technology has been drastically improving medical systems and services to help us live longer and better lives. In this special half-hour episode of'Tomorrow Transformed', connections, partnerships, and collaborations in the wo...

2024-10-03 12:16 2376

Millennium Hotels and Resorts Pledges Solidarity for Breast Cancer Awareness Month

The global hospitality brand announces a collaborative event with breast cancer advocate and survivorJill Alphonso and sound healing expert Michele Chong of The Sirius Sound, alongside pink-themed F&B offerings. SINGAPORE, Oct. 2, 2024 /PRNewswire/ -- Millennium Hotels and Resorts (MHR) announce...

2024-10-03 11:41 2605
1 ... 49505152535455 ... 858